tiprankstipranks
Trending News
More News >
Ainos Inc (AIMD)
:AIMD
US Market

Ainos (AIMD) Price & Analysis

Compare
69 Followers

AIMD Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

19.18%0.18%0.17%80.46%
19.18% Insiders
0.17% Other Institutional Investors
80.46% Public Companies and
Individual Investors

AIMD FAQ

What was Ainos Inc’s price range in the past 12 months?
Ainos Inc lowest stock price was $0.40 and its highest was $1.46 in the past 12 months.
    What is Ainos Inc’s market cap?
    Ainos Inc’s market cap is $8.03M.
      When is Ainos Inc’s upcoming earnings report date?
      Ainos Inc’s upcoming earnings report date is May 19, 2025 which is in 37 days.
        How were Ainos Inc’s earnings last quarter?
        Ainos Inc released its earnings results on Mar 07, 2025. The company reported -$0.302 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.302.
          Is Ainos Inc overvalued?
          According to Wall Street analysts Ainos Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Ainos Inc pay dividends?
            Ainos Inc does not currently pay dividends.
            What is Ainos Inc’s EPS estimate?
            Ainos Inc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Ainos Inc have?
            Ainos Inc has 15,433,257 shares outstanding.
              What happened to Ainos Inc’s price movement after its last earnings report?
              Ainos Inc reported an EPS of -$0.302 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.122%.
                Which hedge fund is a major shareholder of Ainos Inc?
                Currently, no hedge funds are holding shares in AIMD
                ---

                Company Description

                Ainos Inc

                Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Avadel Pharmaceuticals
                MannKind
                Innoviva
                Xoma
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis